Chan Lee Biography and Net Worth

SVP of Beigene

Chan Lee joined BeiGene as General Counsel in July 2022.

Mr. Lee previously worked at Sanofi from 2016 to 2022, where he served as North America General Counsel and Head of Legal for the Specialty Care Global Business Unit, responsible for the legal oversight of the company’s U.S. and Canada businesses and its global Specialty Care business. Prior to Sanofi, he held roles of increasing responsibility from 2008 to 2016 at Pfizer, most notably as Chief Counsel for Pfizer’s Innovative Health global business, and, earlier, as Chief Counsel for the Vaccines, Oncology and Consumer Health global businesses, and as Assistant General Counsel for Asia.

Mr. Lee earned his J.D. from the University of California at Berkeley and his B.S. in applied economics from Cornell University.

How do I contact Chan Henry Lee?: The corporate mailing address for Lee and other Beigene executives is C/O MOURANT GOVERNANCE SERVICES (CAYMAN), 94 SOLARIS AVENUE, CAMANA BAY, GRAND CAYMAN, E9, KY1-1108. Beigene can also be reached via phone at 13459494123 and via email at [email protected]. Learn More on Chan Henry Lee's contact information.
Has Chan Henry Lee been buying or selling shares of Beigene?: During the past quarter, Chan Henry Lee has sold $179,277.00 in shares of Beigene stock. Most recently, Chan Henry Lee sold 700 shares of the business's stock in a transaction on Friday, June 6th. The shares were sold at an average price of $256.11, for a transaction totalling $179,277.00. Learn More on Chan Henry Lee's trading history.
Who are Beigene's active insiders?: Beigene's insider roster includes Chan Lee (SVP), John Oyler (CEO), Lai Wang (Global Head of R&D), Lai Wang (Insider), Xiaodong Wang (Insider), and Xiaobin Wu (COO). Learn More on Beigene's active insiders.
Are insiders buying or selling shares of Beigene?: In the last twelve months, insiders at the sold shares 19 times. They sold a total of 1,238,865 shares worth more than $317,860,315.41. The most recent insider tranaction occured on June, 11th when insider Titus B. Ball sold 134 shares worth more than $34,620.24. Insiders at Beigene own 6.6% of the company. Learn More about insider trades at Beigene.
Information on this page was last updated on 6/11/2025.

Chan Henry Lee Insider Trading History at Beigene

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/6/2025	Sell	700	$256.11	$179,277.00
2/21/2025	Sell	1,202	$258.04	$310,164.08

Chan Henry Lee Buying and Selling Activity at Beigene

Beigene Company Overview

BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.

Today's Range

Now: $272.07

$268.69

$272.82

50 Day Range

MA: $240.18

$206.32

$276.53

2 Week Range

Now: $272.07

$141.31

$287.88

Volume

226,415 shs

Average Volume

449,409 shs

Market Capitalization

$32.21 billion

P/E Ratio

N/A

Dividend Yield